These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6757465)

  • 1. Immunotherapy of murine transitional cell carcinoma.
    Lamm DL; Reichert DF; Harris SC; Lucio RM
    J Urol; 1982 Nov; 128(5):1104-8. PubMed ID: 6757465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF; Lamm DL
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of murine bladder cancer with keyhole limpet hemocyanin (KLH).
    Lamm DL; DeHaven JI; Riggs DR; Ebert RF
    J Urol; 1993 Mar; 149(3):648-52. PubMed ID: 8437283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allium sativum (garlic) treatment for murine transitional cell carcinoma.
    Riggs DR; DeHaven JI; Lamm DL
    Cancer; 1997 May; 79(10):1987-94. PubMed ID: 9149027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keyhole limpet hemocyanin immunotherapy of murine bladder cancer.
    Lamm DL; DeHaven JI; Riggs DR; Delgra C; Burrell R
    Urol Res; 1993 Jan; 21(1):33-7. PubMed ID: 8456536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of murine transitional cell carcinoma of the bladder using alpha and gamma interferon in combination with other forms of immunotherapy.
    Riggs DR; Tarry WF; DeHaven JI; Sosnowski J; Lamm DL
    J Urol; 1992 Jan; 147(1):212-4. PubMed ID: 1729535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of intravesical immunotherapy with Corynebacterium parvum and Allium sativum in control of murine bladder cancer.
    Marsh CL; Torrey RR; Woolley JL; Barker GR; Lau BH
    J Urol; 1987 Feb; 137(2):359-62. PubMed ID: 3806842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylchlorformate polymerized tumor protein immunotherapy of the murine bladder tumor.
    Mori K; Ikemoto S; Nishio S; Maekawa M
    Cancer; 1989 Feb; 63(4):667-70. PubMed ID: 2914272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of intralesional immunotherapy with Corynebacterium parvum and Allium sativum in control of murine transitional cell carcinoma.
    Lau BH; Woolley JL; Marsh CL; Barker GR; Koobs DH; Torrey RR
    J Urol; 1986 Sep; 136(3):701-5. PubMed ID: 3735559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
    Rentsch CA; Birkhäuser FD; Biot C; Gsponer JR; Bisiaux A; Wetterauer C; Lagranderie M; Marchal G; Orgeur M; Bouchier C; Bachmann A; Ingersoll MA; Brosch R; Albert ML; Thalmann GN
    Eur Urol; 2014 Oct; 66(4):677-88. PubMed ID: 24674149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of interleukin 2 and bacillus Calmette-Guérin in the therapy of mice with transitional cell carcinoma.
    Ikemoto S; Kamizuru M; Wada S; Nishio S; Kishimoto T; Maekawa M
    Urol Int; 1991; 47(4):250-4. PubMed ID: 1781111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of murine bladder cancer by irradiated tumor vaccine.
    Lamm DL; Riggs DR; DeHaven JI; Bryner RW
    J Urol; 1991 Jan; 145(1):195-8. PubMed ID: 1984090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins.
    Moltedo B; Faunes F; Haussmann D; De Ioannes P; De Ioannes AE; Puente J; Becker MI
    J Urol; 2006 Dec; 176(6 Pt 1):2690-5. PubMed ID: 17085197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma.
    Walsh WG; Tomashefsky P; Olsson CA; deVere White R
    Urol Res; 1983; 11(6):263-5. PubMed ID: 6659223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific immunotherapy of murine bladder cancer with butanol-extracted antigens and ethylchlorformate polymerized tumor protein.
    Rochester MG; Sarosdy MF; Pickett SH; Stogdill BJ; Lamm DL
    J Urol; 1988 Sep; 140(3):647-50. PubMed ID: 3411695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinoma.
    Lamm DL; Reyna JA; Reichert DF
    Urol Res; 1981; 9(5):227-30. PubMed ID: 7303346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.
    Witjes JA; Dalbagni G; Karnes RJ; Shariat S; Joniau S; Palou J; Serretta V; Larré S; di Stasi S; Colombo R; Babjuk M; Malmström PU; Malats N; Irani J; Baniel J; Cai T; Cha E; Ardelt P; Varkarakis J; Bartoletti R; Spahn M; Pisano F; Gontero P; Sylvester R
    Urol Oncol; 2016 Nov; 34(11):484.e19-484.e25. PubMed ID: 27639776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
    Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.